Tavist (clemastine fumarate)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Sandoz Pharmaceuticals

Approval Status:

Approved November 1996

Specific Treatments:

cold symptoms, including sneezing and runny nose

Therapeutic Areas

Pulmonary/Respiratory Diseases
Family Medicine
Infections and Infectious Diseases

Find Related Trials for The Following Conditions

Common Cold

General Information

Tavist-D has been approved for the treatment of cold symptoms, including sneezing and runny nose. The FDA decision results from well-controlled clinical studies of the antihistamine clemastive fumarate, the active ingredient that differentiates the Tavist product from others.